OMB APPROVAL |
OMB Number: 3235-0416 Expires: July 31, 2011 Estimated average burden hours per response 192.00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________
FORM 10-Q
________
(Mark One) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the quarterly period ended September 30, 2009 |
| OR |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from to
|
Commission File No.000-28423
VALIDIAN CORPORATION
(Exact name of Registrant as specified in its charter)
NEVADA |
| 58-2541997 |
(State or other jurisdiction of |
| (I.R.S. Employer |
incorporation or organization) |
| Identification No.) |
30 Metcalfe Street, Ottawa, Ontario, Canada K1P 5L4
(Address of principal executive offices)
Registrant’s telephone number: 613-230-7211
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer¨ Accelerated filer¨ Non-accelerated filer¨ Smaller reporting companyx
Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):
Yes¨ Nox
APPLICABLE ONLY TO CORPORATE ISSUERS:
At November 13, 2009, 100,248,481 shares of the registrant’s common stock were outstanding.
SEC 2334 (9-05)
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.
1
1
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Balance Sheets
(In United States dollars)
| September 30, |
| December 31, |
| 2009 |
| 2008 |
| (Unaudited) |
|
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 4,110 |
| $ 59,418 |
Amounts receivable | 16,937 |
| 5,823 |
Prepaid expenses | 11,464 |
| 19,864 |
| 32,511 |
| 85,105 |
Property and equipment, net of accumulated depreciation of $216,119 |
|
|
|
(December 31, 2008 - $207,486) | 14,684 |
| 22,263 |
|
|
|
|
Total assets | $ 47,195 |
| $ 107,368 |
Liabilities and Stockholders’ Deficiency |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued liabilities (note 9) | $ 1,790,758 |
| $ 1,419,653 |
Deferred revenue | 155,000 |
| 155,000 |
Promissory notes payable (note 2) | 226,442 |
| 121,537 |
Current portion of capital lease obligation (note 4) | 3,577 |
| 3,025 |
10% Senior convertible notes (note 3) | 5,221,948 |
| 5,030,709 |
Total current liabilities | 7,397,725 |
| 6,729,924 |
|
|
|
|
Capital lease obligation (note 4) | 6,851 |
| 8,489 |
Total liabilities | 7,404,576 |
| 6,738,413 |
|
|
|
|
Stockholders’ deficiency (note 5): |
|
|
|
Common stock, ($0.001 par value. Authorized 300,000,000 shares; issued and outstanding 99,273,481 and 80,284,057 shares at September 30, 2009 and December 31, 2008, respectively.) | 99,273 |
| 80,284 |
Preferred stock ($0.001 par value. Authorized 50,000,000 shares; issued |
|
|
|
and outstanding Nil shares at September 30, 2009 and at December 31, 2008) | -- |
| -- |
Additional paid in capital | 25,965,618 |
| 25,651,643 |
Deficit accumulated during the development stage | (33,393,838) |
| (32,334,538) |
Retained earnings prior to entering development stage | 21,304 |
| 21,304 |
Treasury stock (7,000 shares at June 30, 2009 and December 31, 2008, at cost) | (49,738) |
| (49,738) |
Total stockholders’ deficiency | (7,357,381) |
| (6,631,045) |
|
|
|
|
Basis of presentation (note 1) |
|
|
|
Commitment and contingent liability (note 10) |
|
|
|
Subsequent events (note 13) |
|
| |
Total liabilities and stockholders’ deficiency | $ 47,195 |
| $ 107,368 |
See accompanying notes to unaudited interim consolidated financial statements.
2
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Operations
For the three and nine months ended September 30, 2009 and 2008
And for the Period from August 3, 1999 to September 30, 2009
(In United States dollars)
(Unaudited)
|
|
| Period from | ||
| Three Months Ended | Nine Months Ended | August 3, 1999 | ||
| September 30, | September 30, | To September 30, | ||
| 2009 | 2008 | 2009 | 2008 | 2009 |
Operating expenses (income): |
| ||||
Selling, general and administrative | $ 206,032 | $ 256,750 | $ 423,137 | $ 1,122,646 | $14,678,686 |
Research and development | 60,304 | 428,180 | 132,548 | 654,770 | 9,825,008 |
Depreciation of property and equipment | 2,570 | 989 | 8,633 | 5,084 | 433,881 |
Gain on sale of property and equipment | -- | -- | -- | -- | (7,442) |
Write-off of prepaid services | -- | -- | -- | -- | 496,869 |
Write-off of deferred consulting services | -- | -- | -- | -- | 1,048,100 |
Write-off of accounts receivable | -- | -- | -- | -- | 16,715 |
Write-off of due from related party | -- | -- | -- | -- | 12,575 |
Loss on cash pledged as collateral for operating lease | -- | -- | -- | -- | 21,926 |
Write-down of property and equipment | -- | -- | -- | -- | 14,750 |
| 268,906 | 685,919 | 564,318 | 1,782,500 | 26,541,068 |
|
|
|
|
|
|
Loss before other income (expenses) | (268,906) | (685,919) | (564,318) | (1,782,500) | (26,541,068) |
|
|
|
|
|
|
Other income (expenses): |
|
|
|
|
|
Interest income | -- | -- | -- | -- | 61,728 |
Gain (loss) on extinguishment of debt, accounts |
|
|
|
|
|
payable and accrued liabilities (note 7) | -- | 163,272 | 69,767 | 175,785 | 368,562 |
Interest and financing costs (notes 6 and 9) | (177,106) | (496,364) | (469,023) | (2,234,712) | (7,226,635) |
Foreign exchange gain (loss) | (52,146) | 48,959 | (95,726) | 69,832 | (56,425) |
| (229,252) | (284,133) | (494,982) | (1,989,095) | (6,852,770) |
|
|
|
|
|
|
Net loss | $(498,158) | $(970,052) | $(1,059,300) | $(3,771,595) | $(33,393,838) |
|
|
|
|
|
|
Loss per share – basic and diluted (note 8) | $(0. 01) | $(0.02) | $(0.01) | $(0.07) |
|
|
|
|
|
|
|
Weighted average number of common shares outstanding during period | 94,147,548 | 59,773,553 | 85,545,195 | 56,463,524 |
|
See accompanying notes to unaudited interim consolidated financial statements.
3
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other compre- hensive income (loss) | Treasury stock | Total |
|
|
|
|
|
|
|
|
|
Balances at December 31, 1998 | 61,333 | $ 61 | $ 23,058 | $ 30,080 | $ – | $ (7,426) | $ – | $ 45,773 |
Issued for mining claims | 92,591 | 92 | 27,408 | – | – | – | – | 27,500 |
Issued for cash | 3,000,000 | 3,000 | 27,000 | – | – | – | – | 30,000 |
Reverse acquisition | 8,459,000 | 8,459 | 21,541 | – | – | – | – | 30,000 |
Fair value of warrants issued to unrelated parties | – | – | 130,000 | – | – | – |
| 130,000 |
Shares issued upon exercise of warrants | 380,000 | 380 | 759,620 | – | – | – |
| 760,000 |
Share issuance costs | – | – | (34,750) | – | – | – | – | (34,750) |
Comprehensive loss: |
|
|
|
|
|
| – |
|
Net loss | – | – | – | (8,776) | (743,410) | – | – | (752,186) |
Currency translation adjustment | – | – | – | – | – | 11,837 | – | 11,837 |
Comprehensive loss |
|
|
|
|
|
|
| (740,349) |
Balances at December 31, 1999 | 11,992,924 | 11,992 | 953,877 | 21,304 | (743,410) | 4,411 | – | 248,174 |
|
|
|
|
|
|
|
|
|
Shares issued upon exercise of warrants | 620,000 | 620 | 1,239,380 | – | – | – |
| 1,240,000 |
Share issuance costs | – | – | (62,000) | – | – | – | – | (62,000) |
Acquisition of common stock | – | – | – | – | – | – | (49,738) | (49,738) |
Comprehensive loss: |
|
|
|
|
|
|
|
|
Net loss | – | – | – | – | (2,932,430) | – | – | (2,932,430) |
Currency translation adjustment | – | – | – | – | – | (40,401) | – | (40,401) |
Comprehensive loss |
|
|
|
|
|
|
| (2,972,831) |
Balances at December 31, 2000 | 12,612,924 | 12,612 | 2,131,257 | 21,304 | (3,675,840) | (35,990) |
| (1,596,395) |
Shares issued in exchange for debt | 2,774,362 | 2,774 | 2,216,715 | – | – | – |
| 2,219,489 |
Fair value of warrants issued to unrelated parties |
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
Net loss | – | – | – | – | (1,448,485) | – | – | (1,448,485) |
Currency translation adjustment | –
| – | – | –
| – | 62,202 | – | 62,202 |
Comprehensive loss |
|
|
|
|
|
|
| (1,386,283) |
Balances at December 31, 2001 | 15,387,286 | $15,386 | $4,799,472 | $21,304 | $(5,124,325) | $26,212 | $(49,738) | $(311,689) |
See accompanying notes to unaudited interim consolidated financial statements.
4
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering develop- ment stage | Deficit accumulated during development stage | Accumulated other compre- hensive income (loss) | Treasury | Total |
|
|
|
|
|
|
|
|
|
Balances at December 31, 2001 | 15,387,286 | $ 15,386 | $ 4,799,472 | $ 21,304 | $ (5,124,325) | $ 26,212 | $ (49,738) | $ (311,689) |
|
|
|
|
|
|
|
|
|
Shares issued in consideration |
|
|
|
|
|
|
|
|
of consulting services | 340,500 | 340 | 245,810 | – | – | – | – | 246,150 |
Comprehensive loss: |
|
|
|
|
|
|
|
|
Net loss | – | – | – | – | (906,841) | – | – | (906,841) |
Currency translation adjustment on liquidation of investment in foreign subsidiary | – | – | – | – | – | (26,212) | – | (26,212) |
Comprehensive loss |
|
|
|
|
|
|
| (933,053) |
Balances at December 31, 2002 | 15,727,786 | 15,726 | 5,045,282 | 21,304 | (6,031,166) | – | (49,738) | (998,592) |
Shares issued in exchange for debt | 4,416,862 | 4,417 | 1,453,147 | – | – | – | – | 1,457,564 |
Shares issued in consideration of consulting and financing services | 422,900 | 423 | 230,448 | – | – | – | – | 230,871 |
Fair value of warrants issued to unrelated parties for services | – | – | 2,896,042 | – | – | – | – | 2,896,042 |
Fair value of stock purchase options issued to unrelated parties for services Relative fair value of warrants issued to investors in conjunction with 4% senior subordinated convertible debentures Intrinsic value of beneficial conversion feature on 4% convertible debentures issued to unrelated parties | – – – | – – – | 597,102 355,186 244,814 | – – – | – – – | – – – | – – – | 597,102 355,186 244,814 |
Net loss and comprehensive loss | – | – | – | – | (3,001,900) | – | – | (3,001,900) |
Balances at December 31, 2003 | 20,567,548 | $ 20,566 | $10,822,021 | $ 21,304 | $ (9,033,066) | $ – | $ (49,738) | $ 1,781,087 |
See accompanying notes to unaudited interim consolidated financial statements.
5
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other comprehensive income (loss) | Treasury stock | Total |
|
|
|
|
|
|
|
|
|
Balances at December 31, 2003 | 20,567,548 | $ 20,566 | $10,822,021 | $21,304 | $(9,033,066) | $ – | $(49,738) | $1,781,087 |
Shares issued in exchange for debt | 464,000 | 464 | 429,536 | – | – | – | – | 430,000 |
Shares issued on conversion of 4% senior subordinated convertible debentures | 2,482,939 | 2,483 | 1,238,986 | – | – | – | – | 1,241,469 |
Deferred financing costs transferred to additional paid in capital on conversion of 4% senior subordinated convertible debentures into common shares | – | – | (721,097) | – | – | – | – | (721,097) |
Shares issued pursuant to private placement of common shares and warrants | 6,666,666 | 6,667 | 5,993,333 | – | – | – | – | 6,000,000 |
Cost of share issuance pursuant to private placement | – | – | (534,874) | – | – | – | – | (534,874) |
Shares issued in consideration of consulting and financing services | 70,000 | 70 | 72,730 | – | – | – | – | 72,800 |
Shares issued in consideration of penalties on late registration of shares underlying the 4% senior subordinated convertible debentures | 184,000 | 184 | 110,216 | – | – | – | – | 110,400 |
Fair value of stock purchase warrants issued to unrelated parties for services | – | – | 809,750 | – | – | – | – | 809,750 |
Relative fair value of warrants issued to investors in conjunction with 4% senior subordinated convertible debentures | – | $ – | $ 861,522 | $ –
| $ – | $ – | $ – | $ 861,522 |
See accompanying notes to unaudited interim consolidated financial statements.
6
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other comprehensive income (loss) | Treasury stock | Total |
|
|
|
|
|
|
|
|
|
Intrinsic value of beneficial conversion feature on 4% convertible debentures issued to unrelated parties | – | – | 538,478 | – | – | – | – | 538,478 |
Net loss and comprehensive loss | – | – | – | – | (8,017,166) | – | – | (8,017,166) |
Balances at December 31, 2004 | 30,435,153 | 30,434 | 19,620,601 | 21,304 | (17,050,232) | –
| (49,738) | 2,572,369 |
Shares issued on conversion of 4% senior subordinated convertible debentures | 1,157,866 | 1,158 | 577,774 | – | – | – | – | 578,932 |
Shares issued in settlement of 4% senior subordinated convertible debentures at maturity | 485,672 | 486 | 242,349 | – | – | – | – | 242,835 |
Deferred financing costs transferred to additional paid in capital on conversion of 4% senior subordinated convertible debentures into common shares | – | – | (163,980) | – | – | – | – | (163,980) |
Fair value of stock purchase options issued to unrelated parties for services rendered | – | – | 211,496 | – | – | – | – | 211,496 |
Fair value of modifications to stock purchase warrants previously issued to unrelated parties | – | – | 61,162 | – | – | – | – | 61,162 |
Shares issued on the exercise of stock purchase warrants | 805,000 | 805 | 401,695 | – | – | – | – | 402,500 |
Net loss and comprehensive loss | – | – | – | – | (4,205,659) | – | – | (4,205,659) |
|
|
|
|
|
|
|
|
|
Balances at December 31, 2005 | 32,883,691 | $ 32,883 | $20,951,097 | $ 21,304 | $ (21,255,891) | $ -
| $(49,738) | $ (300,345) |
See accompanying notes to unaudited interim consolidated financial statements.
7
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other comprehensive income (loss) | Treasury stock | Total |
|
|
|
|
|
|
|
|
|
Balances at December 31, 2005 | 32,883,691 | $ 32,883 | $20,951,097 | $ 21,304 | $ (21,255,891) | $ – | $(49,738) | $ (300,345) |
Shares issued in consideration of consulting services | 800,000 | 800 | 106,700 | – | – | – | – | 107,500 |
Fair value of employee stock options earned during period | – | – | 28,689 | – | – | – | – | 28,689 |
Reversal of fair value of unvested employee stock options recognized in the current and prior periods, on forfeiture of the options | – | – | (9,939) | – | – | – | – | (9,939) |
Shares issued on the exercise of stock purchase warrants | 20,000 | 20 | 9,980 | – | – | – | – | 10,000 |
Shares issued pursuant to the terms of the 10% senior convertible notes | 2,800,000 | 2,800 | 401,602 | – | – | – | – | 404,402 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the 10% promissory |
|
|
|
|
|
|
|
|
note | 1,000,000 | 1,000 | 149,000 | – | – | – | – | 150,000 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of an agreement to extend |
|
|
|
|
|
|
|
|
the payment terms of finance fees |
|
|
|
|
|
|
|
|
payable | 100,000 | 100 | 11,400 | – | – | – | – | 11,500 |
Shares issued in satisfaction of |
|
|
|
|
|
|
|
|
finance fees payable, which were |
|
|
|
|
|
|
|
|
included in accounts payable and |
|
|
|
|
|
|
|
|
accrued liabilities | 250,000 | 250 | 28,500 | – | – | – | – | 28,750 |
Intrinsic value of beneficial conversion feature on the 10% senior convertible notes | – | – | 515,297 | – | – | – | – | 515,297 |
Shares issued in satisfaction of |
|
|
|
|
|
|
|
|
interest payable | 118,378 | 119 | 13,519 | – | – | – | – | 13,638 |
Shares issued in satisfaction of |
|
|
|
|
|
|
|
|
penalty for non-timely payment |
|
|
|
|
|
|
|
|
of the 10% promissory note | 500,000 | 500 | 44,500 | – | – | – | – | 45,000 |
Shares issued in consideration for |
|
|
|
|
|
|
|
|
finance fees related to the |
|
|
|
|
|
|
|
|
issuance of convertible and |
|
|
|
|
|
|
|
|
promissory notes | 740,000 | 740 | 75,720 | – | – | – | – | 76,460 |
Net loss and comprehensive loss | – | – | – | – | (3,387,291) | – | – | (3,387,291) |
Balances at December 31, 2006 | 39,212,069 | $ 39,212 | $22,326,065 | $ 21,304 | $ (24,643,182) | $ -
| $(49,738) | $ (2,306,339) |
See accompanying notes to unaudited interim consolidated financial statements
8
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other comprehensive income (loss) | Treasury stock | Total |
Balances at December 31, 2006 | 39,212,069 | $ 39,212 | $22,326,065 | $ 21,304 | $ (24,643,182) | $ - | $(49,738) | $ (2,306,339) |
Shares issued in consideration of |
|
|
|
|
|
|
|
|
consulting services rendered |
|
|
|
|
|
|
|
|
and to be rendered | 4,105,000 | 4,105 | 180,045 | – | – | – | – | 184,150 |
Shares issued in consideration of |
|
|
|
|
|
|
|
|
finance fees relating to the |
|
|
|
|
|
|
|
|
issuance of 10% senior |
|
|
|
|
|
|
|
|
convertible notes | 149,333 | 149 | 6,511 | – | – | – | – | 6,660 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accrued liabilities | 1,275,000 | 1,275 | 45,900 | – | – | – | – | 47,175 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accrued interest on the 10% |
|
|
|
|
|
|
|
|
senior convertible notes | 659,001 | 659 | 39,228 | – | – | – | – | 39,887 |
Fair value of employee stock |
|
|
|
|
|
|
|
|
options earned during the period | – | – | 2,727 | – | – | – | – | 2,727 |
Incremental value of stock |
|
|
|
|
|
|
|
|
options issued during the period |
|
|
|
|
|
|
|
|
in exchange for the repurchase |
|
|
|
|
|
|
|
|
and cancellation of options |
|
|
|
|
|
|
|
|
previously issued | – | – | 106,933 | – | – | – | – | 106,933 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the 10% senior |
|
|
|
|
|
|
|
|
convertible notes at issuance | 2,790,566 | 2,791 | 180,132 | – | – | – | – | 182,923 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the 10% senior |
|
|
|
|
|
|
|
|
convertible notes on resolution |
|
|
|
|
|
|
|
|
of the contingency | 810,000 | 810 | 98,418 | – | – | – | – | 99,228 |
Intrinsic value of the beneficial |
|
|
|
|
|
|
|
|
conversion feature of the 10% |
|
|
|
|
|
|
|
|
senior convertible notes at date |
|
|
|
|
|
|
|
|
of issuance | -- | -- | 188,767 | -- | -- | -- | -- | 188,767 |
Relative fair value of warrants |
|
|
|
|
|
|
|
|
issued pursuant to the terms of |
|
|
|
|
|
|
|
|
the 10% senior convertible notes | – | – | 102,515 | – | – | – | – | 102,515 |
|
|
|
|
|
|
|
|
|
Intrinsic value of the beneficial |
|
|
|
|
|
|
|
|
conversion feature of the 10% |
|
|
|
|
|
|
|
|
senior convertible notes on |
|
|
|
|
|
|
|
|
resolution of the contingency | – | – | 540,031 | – | – | – | – | 540,031 |
Adjustment to the relative fair |
|
|
|
|
|
|
|
|
value of warrants issued |
|
|
|
|
|
|
|
|
pursuant to the terms of the 10% |
|
|
|
|
|
|
|
|
senior convertible notes on |
|
|
|
|
|
|
|
|
resolution of the contingency | – | – | 77,222 | – | – | – | – | 77,222 |
See accompanying notes to unaudited interim consolidated financial statements
9
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
| Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated other comprehensive income (loss) | Treasury stock | Total |
Shares issued on conversion of |
|
|
|
|
|
|
|
|
10% senior convertible notes | 572,194 | $ 572 | $ 52,455 | $ – | $ – | $ – | $ – | $ 53,027 |
Fair value of warrants issued in |
|
|
|
|
|
|
|
|
consideration of consulting |
|
|
|
|
|
|
|
|
services rendered | – | – | 108,675 | – | – | – | – | 108,675 |
Fair value of options issued in |
|
|
|
|
|
|
|
|
consideration of consulting |
|
|
|
|
|
|
|
|
services rendered and to be |
|
|
|
|
|
|
|
|
rendered | – | – | 20,969 | – | – | – | – | 20,969 |
Net loss and comprehensive loss | – | – | – | – | (3,726,393) | – | – | (3,726,393) |
|
|
|
|
|
|
|
|
|
Balances at December 31, 2007 | 49,573,163 | 49,573 | 24,076,593 | 21,304 | (28,369,575) | – | (49,738) | (4,271,843) |
|
|
|
|
|
|
|
|
|
Shares issued in consideration |
|
|
|
|
|
|
|
|
of consulting contract |
|
|
|
|
|
|
|
|
incentive payment | 3,000,000 | 3,000 | 237,000 | – | – | – | – | 240,000 |
Shares issued as partial |
|
|
|
|
|
|
|
|
consideration for consulting |
|
|
|
|
|
|
|
|
services rendered and to |
|
|
|
|
|
|
|
|
be rendered | 2,250,000 | 2,250 | 51,950 | – | – | – | – | 54,200 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the promissory notes |
|
|
|
|
|
|
|
|
at issuance | 766,667 | 767 | 20,291 | – | – | – | – | 21,058 |
Shares issued in connection |
|
|
|
|
|
|
|
|
with the conversion of 10% |
|
|
|
|
|
|
|
|
senior convertible notes | 6,404,818 | 6,405 | 361,897 | – | – | – | – | 368,302 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the 10% senior |
|
|
|
|
|
|
|
|
convertible notes at issuance | 4,910,852 | 4,911 | 160,233 | – | – | – | – | 165,144 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accounts payable and accrued |
|
|
|
|
|
|
|
|
liabilities | 11,293,396 | 11,293 | 250,662 | – | – | – | – | 261,955 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accrued interest on the 10% |
|
|
|
|
|
|
|
|
senior convertible notes | 2,085,161 | 2,085 | 45,557 | – | – | – | – | 47,642 |
Intrinsic value of the beneficial |
|
|
|
|
|
|
|
|
conversion feature of the 10% |
|
|
|
|
|
|
|
|
senior convertible notes at |
|
|
|
|
|
|
|
|
date of issuance | – | – | 329,282 | – | – | – | – | 329,282 |
Fair value of vested options |
|
|
|
|
|
|
|
|
issued to employees and |
|
|
|
|
|
|
|
|
consultants in consideration |
|
|
|
|
|
|
|
|
for services rendered and |
|
|
|
|
|
|
|
|
to be rendered | – | – | 113,459 | – | – | – | – | 113,459 |
Fair value of unvested stock |
|
|
|
|
|
|
|
|
options earned during the |
|
|
|
|
|
|
|
|
year | – | – | 4,719 | – | – | – | – | 4,719 |
Net loss and comprehensive |
|
|
|
|
|
|
|
|
loss | – | – | – | – | (3,964,963) | – | – | (3,964,963) |
Balances at December 31, 2008 | 80,284,057 | $ 80,284 | $25,651,643 | $ 21,304 | $ (32,334,538) | $ – | $(49,738) | $(6,631,045) |
See accompanying notes to unaudited interim consolidated financial statements
10
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) and Comprehensive Loss
For the period from December 31, 1998 to September 30, 2009
(In United States dollars)
(Unaudited)
Number | Common stock amount | Additional paid-in capital | Retained earnings prior to entering development stage | Deficit accumulated during development stage | Accumulated Other comprehensive income (loss) | Treasury stock | Total | |
Balances at December 31, 2008 | 80,284,057 | $ 80,284 | $25,651,643 | $ 21,304 | $ (32,334,538) | $ – | $(49,738) | $(6,631,045) |
|
|
|
|
|
|
|
|
|
Shares issued in consideration |
|
|
|
|
|
|
|
|
for finance fees | 100,000 | 100 | 1,300 | – | – | – | – | 1,400 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the promissory notes |
|
|
|
|
|
|
|
|
at issuance (note 2) | 366,250 | 366 | 4,221 | – | – | – | – | 4,587 |
Shares issued pursuant to the |
|
|
|
|
|
|
|
|
terms of the 10% senior |
|
|
|
|
|
|
|
|
convertible notes at issuance |
|
|
|
|
|
|
|
|
(note 3) | 3,725,000 | 3,725 | 46,140 | – | – | – | – | 49,865 |
Intrinsic value of the beneficial |
|
|
|
|
|
|
|
|
conversion feature of the 10% |
|
|
|
|
|
|
|
|
senior convertible notes at |
|
|
|
|
|
|
|
|
date of issuance | – | – | 2,617 | – | – | – | – | 2,617 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accrued interest on the 10% |
|
|
|
|
|
|
|
|
senior convertible notes |
|
|
|
|
|
|
|
|
(note 5(a)) | 7,261,508 | 7,261 | 83,259 | – | – | – | – | 90,520 |
Shares issued in connection |
|
|
|
|
|
|
|
|
with the conversion of 10% |
|
|
|
|
|
|
|
|
senior convertible notes |
|
|
|
|
|
|
|
|
(note 5(a)) | 3,603,333 | 3,603 | 104,497 | – | – | – | – | 108,100 |
Fair value of stock options earned |
|
|
|
|
|
|
|
|
during the period (note 5(b)) | – | – | 6,275 | – | – | – | – | 6,275 |
Shares issued in consideration |
|
|
|
|
|
|
|
|
of consulting contract |
|
|
|
|
|
|
|
|
incentive payments | 1,800,000 | 1,800 | 27,800 | – | – | – | – | 29,600 |
Shares issued as partial |
|
|
|
|
|
|
|
|
consideration for consulting |
|
|
|
|
|
|
|
|
services rendered | 1,800,000 | 1,800 | 34,200 | – | – | – | – | 36,000 |
Shares issued in settlement of |
|
|
|
|
|
|
|
|
accounts payable and accrued |
|
|
|
|
|
|
|
|
liabilities | 333,333 | 334 | 3,666 | – | – | – | – | 4,000 |
Net loss and comprehensive |
|
|
|
|
|
|
|
|
loss | – | – | – | – | (1,059,300) | – | – | (1,059,300) |
Balances at September 30, 2009 | 99,273,481 | $ 99,273 | $25,965,618 | $ 21,304 | $ (33,393,838) | $ – | $(49,738) | $(7,357,381) |
See accompanying notes to unaudited interim consolidated financial statements
11
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30, 2009 and 2008
And for the Period from August 3, 1999 to September 30, 2009
(In United States dollars)
(Unaudited)
| Nine Months Ended September 30, | Period from August 3, 1999 to | |
| 2009 | 2008 | September 30, 2009 |
Cash flows from operating activities: | |||
Net loss | $ (1,059,300) | $(3,771,595) | $ (33,393,838) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
Depreciation of property and equipment | 8,633 | 5,084 | 433,881 |
Stock-based compensation | 73,422 | 391,523 | 3,492,522 |
Non-cash interest and financing expense | 459,526 | 2,231,610 | 7,208,807 |
Loss (gain) on extinguishment of debt and accrued liabilities | (69,767) | (175,785) | (368,562) |
Non-cash penalties | -- | -- | 166,900 |
Write-off of prepaid services | -- | -- | 496,869 |
Write-off of deferred consulting services | -- | -- | 1,048,100 |
Currency translation adjustment on liquidation of investment in foreign subsidiary | -- | -- | (26,212) |
Gain on sale of property and equipment | -- | -- | (7,442) |
Write-off of accounts receivable | -- | -- | 16,715 |
Write-off of due to related party | -- | -- | 12,575 |
Loss on cash pledged as collateral for operating lease | -- | -- | 21,926 |
Write-down of property and equipment | -- | -- | 14,750 |
Increase (decrease) in cash resulting from changes in: |
|
|
|
Amounts receivable | (11,114) | 3,653 | (5,174) |
Prepaid expenses | 6,852 | 9,856 | (58,982) |
Accounts payable and accrued liabilities | 176,955 | 490,120 | 4,165,943 |
Deferred revenue | -- | -- | 155,000 |
Due to a related party | -- | -- | (5,178) |
Net cash used in operating activities | (414,793) | (815,534) | (16,631,400) |
Cash flows from investing activities: |
|
|
|
Additions to property and equipment | (1,054) | (2,482) | (537,827) |
Proceeds on sale of property and equipment | -- | -- | 176,890 |
Cash pledged as collateral for operating lease | -- | -- | (21,926) |
Net cash used in investing activities | (1,054) | (2,482) | (382,863) |
Cash flows from financing activities: |
|
|
|
Capital lease repayments | (1,086) | (1,629) | (20,061) |
Issuance of promissory notes | 160,358 | 516,892 | 4,688,490 |
Issuance of 10% senior convertible notes | 260,000 | 385,000 | 2,995,000 |
Debt and equity issuance costs | -- | (13,000) | (932,983) |
Repayment of promissory notes | (70,530) | (41,000) | (156,385) |
Proceeds from exercise of stock purchase warrants | -- | -- | 412,500 |
Increase in due from related party | -- | -- | 12,575 |
Issuance of common shares | -- | -- | 8,030,000 |
Redemption of common stock | -- | -- | (49,738) |
Issuance of 4% senior subordinated convertible debentures | -- | -- | 2,000,000 |
Net cash provided by financing activities | 348,742 | 846,263 | 16,979,398 |
|
|
|
|
Effects of exchange rates on cash and cash equivalents | 11,797 | (25,028) | 4,176 |
Net increase (decrease) in cash and cash equivalents | (55,308) | 3,219 | (30,689) |
Cash and cash equivalents: |
|
|
|
Beginning of period | 59,418 | 5,120 | 34,799 |
End of period | $ 4,110 | $ 8,339 | $ 4,110 |
|
|
|
|
See accompanying notes to unaudited interim consolidated financial statements.
12
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
Validian Corporation (the “Company”) was incorporated in the State of Nevada on April 12, 1989 as CCC Funding Corp. The Company underwent several name changes before being renamed to Validian Corporation on January 28, 2003.
Since August 3, 1999, the efforts of the Company have been devoted primarily to the development of a high speed, highly secure method of exchanging data files using the internet, and to the sale and marketing of the Company’s products. Prior to August 3, 1999, the Company conducted business in an unrelated field. As the Company commenced development activities on this date, it is considered for financial accounting purposes to be a development stage enterprise and August 3, 1999 is the commencement of the development stage.
1. Basis of presentation
The accompanying consolidated financial statements include the accounts of Validian Corporation and its wholly owned subsidiaries (collectively, the "Company") after elimination of all significant intercompany balances and transactions. The financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. While management has based its assumptions and estimates on the facts and circumstances currently known, final amounts may differ from such estimates.
The interim financial statements contained herein are unaudited but, in the opinion of management, include all adjustments (consisting only of normal recurring entries) necessary for a fair presentation of the financial position and results of operations of the Company for the periods presented. The results of operations for the three and nine months ended September 30, 2009 are not necessarily indicative of the operating results for the full fiscal year ending December 31, 2009. These unaudited interim financial statements have been prepared following accounting principles consistent with those used in the annual audited financial statements and should be read in conjunction with the annual audited financial statements for the year ended December 31, 2008, except for the following accounting pronouncements: In June 2009, the FASB issued Statement No. 168 “The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles, a replacement of FASB Statement No. 162” (the Codification). The Codification has become the single source of authoritative non-government U.S. generally accepted accounting principles (GAAP), superseding various existing authoritative accounting pronouncements. The Codification eliminates the GAAP hierarchy contained in Statement No. 162 and establishes one level of authoritative GAAP. All other U.S. GAAP literature is considered non-authoritative. This Codification is effective for financial statements issued for interim and annual periods ending after September 15, 2009. We have adopted the Codification in our third quarter of Fiscal 2009. There was no change to our consolidated financial statements due to the implementation of the Codification other than changes in reference to various authoritative accounting pronouncements in our Notes to consolidated financial statements. In June 2009 the Company adopted FASB Accounting Standards Codification Topic 855 47;Subsequent Events. Topic 855 requires management to evaluate subsequent events through the date the financial statements are either issued or available to be issued, depending on the company’s expectation of whether it will widely distribute its financial statements to its shareholders and other financial statement users. Companies are required to disclose the date through which subsequent events have been evaluated. Topic 855 is effective for interim or annual financial periods ending after June 15, 2009. The Company adopted the provisions of Topic 855 on June 30, 2009. The adoption of Topic 855 did not have a material impact on The Company’s results of operations and financial condition.
The consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has no revenues, has negative working capital of $7,365,214 and stockholders’ deficiency of $7,357,381 as at September 30, 2009, and has incurred a loss of $1,059,300 and negative cash flow from operations of $414,793 for the nine months then ended. The Company expects to continue to incur operating losses for the foreseeable future, and has no lines of credit or other financing facilities in place. Furthermore, the Company failed to settle certain 10% senior convertible notes and promissory notes plus accrued interest when they matured in 2008 and 2009. As a result of these non-payment defaults, all of the 10% senior convertible notes, as well as $137,698 of the promissory notes were in default at September 30, 2009, in accordance with the default provisions of the respective notes, and consequently are due and payable on demand.
13
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
1. Basis of presentation (continued)
The Company expects to incur operating expenses of approximately $800,000 for the year ending December 31, 2009, subject to the availability of adequate funding. In the event the Company cannot raise the additional funds necessary to finance its research and development and sales and marketing activities, it may have to cease operations.
All of the factors above raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plan to address these issues includes raising capital through the private placement of equity, the exercise of previously-issued equity instruments and through the issuance of additional promissory notes. The Company’s ability to continue as a going concern is subject to management’s ability to successfully implement these plans. Failure to do so could have a material adverse effect on the Company’s position and or results of operations and could also result in the Company ceasing operations. The consolidated financial statements do not include adjustments that would be required if the assets are not realized and the liabilities settled in the normal course of operations.
Even if successful in obtaining financing in the near term, the Company cannot be certain that cash generated from its future operations will be sufficient to satisfy its liquidity requirements in the longer term, and it may need to continue to raise capital by issuing additional equity or by obtaining credit facilities. The Company’s future capital requirements will depend on many factors, including, but not limited to, the market acceptance of its products and the level of its promotional activities and advertising required to generate product sales. No assurance can be given that any such additional funding will be available or that, if available, it can be obtained on terms favorable to the Company.
2. Promissory notes payable
| September 30, | December 31, |
| 2009 | 2008 |
| (unaudited) |
|
Due on demand, interest at 12%, unsecured | $ 126,442 | $ 21,537 |
Due on demand, interest at 10%, unsecured | 100,000 | 100,000 |
| $ 226,442 | $ 121,537 |
During the nine months ended September 30, 2009, the Company issued $163,638 in principal amount of its promissory notes, and repaid $70,530 in principal amount of the notes. $3,280 of the notes were issued in settlement of accrued liabilities; $160,358 of the notes were issued at a $8,725 discount, for net cash proceeds of $151,633. Holders of $80,509 of the notes issued during the period were granted 366,250 common shares of the Company at the date of issuance. $4,587, representing the relative fair value of the common shares at the issuance date, was allocated to the common shares par value and additional paid in capital; the notes balance was accreted through charges to interest and financing expense.
The Company failed to settle certain of the 10% senior convertible notes when they matured in 2008, which resulted in $100,000 of the promissory notes outstanding at the date of default becoming immediately due and payable in accordance with the default provisions of the promissory notes. As of September 30, 2009, these notes, as well as $37,698 of notes issued since the occurrence of the initial event of default, plus $15,133 in interest thereon, are in default.
14
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
3. 10% Senior convertible notes
The following table sets forth the financial statement presentation of the note proceeds on issuance, and the changes in financial statement presentation of the balance allocated to the 10% senior convertible notes for the periods ended September 30, 2009 and December 31, 2008:
| Nine months | Year |
| Ended | Ended |
| September 30, 2009 | December 31, 2008 |
| (unaudited) |
|
Balance beginning of period | $ 5,030,709 | $ 2,053,344 |
|
|
|
Note proceeds on issuance | 1,426,571 | 3,265,248 |
Allocated to common stock and additional paid-in capital for the relative |
|
|
fair value of stock issued to holders of the notes: |
|
|
Allocated to common stock | (3,725) | (4,911) |
Allocated to additional paid-in capital | (46,140) | (160,233) |
| (49,865) | (165,144) |
Allocated to additional paid-in capital for the intrinsic value of the |
|
|
beneficial conversion feature | (2,617) | (329,282) |
Proceeds allocated to 10% senior convertible notes on issuance | 1,374,089 | 2,770,822 |
|
|
|
Accretion recorded as a charge to interest and financing costs | 52,482 | 1,838,815 |
Principal converted pursuant to the terms of the notes | (108,100) | (332,272) |
Principal matured and repaid through the issuance of new notes | (1,127,232) | (1,300,000) |
| $ 5,221,948 | $ 5,030,709 |
During the nine months ended September 30, 2009, the Company issued an aggregate of $1,426,571 of its 10% senior convertible notes, and settled an aggregate of $1,127,232 of these notes. $260,000 of the notes issued during the period were issued for cash; $20,000 were issued in settlement of $20,000 in accounts payable; and $1,146,571 of the notes were issued as consideration for the repayment of $1,127,232 in previously issued 10% senior convertible notes, plus $19,339 in accrued interest thereon.
Under the terms of the notes issued during the nine months ended September 30, 2009, the holders are permitted, at any time, to convert all or a portion of the outstanding principal plus accrued interest into common stock of the company, at a rate of one common share for each $0.03 of debt converted. The Company has the option of pre-paying all or any portion of the balance outstanding on the notes at any time, without penalty or bonus, with the permission of the holders. Interest on the notes is accrued until the notes are either repaid by the Company or converted by the holder; holders of $230,117 of the notes are also entitled to receive payment of accrued interest on submission to the Company of a written request. At the Company’s option, interest may be paid either in cash or in common shares of the Company. If interest is paid in common shares, the number of shares required for settlement will be calculated at the rate of conversion in ef fect for the conversion of the note principal. $1,226,571 of the notes mature on dates between December 31, 2009 and December 31, 2010; $200,000 of the notes are payable on demand.
Holders of the notes issued during the nine months ended September 30, 2009 were granted 3,725,000 common shares of the Company upon issuance of the notes; $49,865, representing the relative fair value of the common shares at the issuance date, was allocated to the common shares par value and additional paid in capital.
At the date of issuance, the conversion feature of $10,000 of the notes was in-the-money. $2,617, representing the relative fair value of the beneficial conversion feature, was allocated to additional paid in capital.
15
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
3. 10% Senior convertible notes (continued)
Also during the nine months ended September 30, 2009, holders of the Company’s 10% senior convertible notes exercised their conversion option and converted $108,100 in principal in exchange for 3,603,333 shares of common stock.
The Company failed to settle $1,800,000 in 10% senior convertible notes plus accrued interest thereon of $277,082 when they matured in 2008, and $3,232,302 in 10% senior convertible notes plus accrued interest thereon of $347,404 when they matured during the nine months ended September 30, 2009. At September 30, 2009, a significant portion of these notes remained in default for non payment. As a result of these non-payment defaults, all of the 10% senior convertible notes are in default at September 30, 2009, in accordance with the default provisions of the notes, and consequently are payable on demand, notwithstanding stated maturity dates ranging from on demand to December 31, 2010. Interest is accrued at the coupon rate on all notes outstanding past the maturity date.
The following table summarizes information regarding the 10% senior convertible notes outstanding at September 30, 2009:
Note | Conversion |
Principal | Rate |
$ 4,170,441 | $0.03 |
511,507 | 0.038 |
15,000 | 0.06 |
525,000 | 0.10 |
$ 5,221,948 |
|
At September 30, 2009, $2,215,134 of the 10% senior convertible notes were secured by a first position lien on all of the assets of the Company. The remaining $3,006,814 were unsecured.
4. Capital lease obligation:
In August, 2008, the Company entered into a long-term lease arrangement for office equipment. Future minimum payments remaining under this obligation are approximately as follows:
|
|
Twelve months ending September 30: |
|
2010 | $ 4,178 |
2011 | 4,178 |
2012 | 3,134 |
Total minimum lease payments | 11,490 |
Less amount representing interest, at 6.61% | 1,062 |
Present value of minimum lease payments | 10,428 |
Current portion of capital lease obligation | 3,577 |
| $ 6,851 |
5. Stockholders’ deficiency
(a) Common stock transactions
During the nine months ended September 30, 2009, the Company issued 100,000 shares of its common stock, valued at $1,400, as consideration for finance fees incurred on the placement of its promissory notes.
In connection with the issuance of the Company’s promissory notes during the nine months ended September 30, 2009, the Company issued 366,250 of its common shares, with a relative fair value of $4,587, to the holders of the notes (note 2).
16
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
5. Stockholders’ deficiency (continued)
(a) Common stock transactions (continued)
In connection with the issuance of the Company’s 10% senior convertible notes during the nine months ended September 30, 2009, the Company issued 3,725,000 of its common shares, with a relative fair value of $49,865, to the holders of the notes (note 3).
During the nine months ended September 30, 2009, the Company issued 7,261,508 shares of its common stock, valued at $90,520, to the holders of the 10% senior convertible notes, in satisfaction of $154,287 of accrued interest on the notes. A gain of $63,767 on the settlement of accrued interest was recognized in connection with this transaction.
Also during the nine months ended September 30, 2009, holders of the Company’s 10% senior convertible notes exercised their conversion option and converted $108,100 in principal in exchange for 3,603,333 shares of common stock.
During the nine months ended September 30, 2009, the Company issued an aggregate of 1,800,000 shares of its common stock, valued at $29,600, as incentives in connection with three consulting services agreements, under which services are to be provided to the Company for an indefinite period of time. $29,600, representing the fair value of the stock issued, has been included in selling, general and administrative expenses.
On June 30, 2009, the Company issued 333,333 shares of its common stock, valued at $4,000, in settlement of $10,000 in accounts payable. A gain of $6,000 on the settlement of accounts payable was recognized in connection with this transaction.
On August 17, 2009, the Company issued an aggregate of 1,800,000 shares of its common stock, valued at $36,000, as a bonus to consultants for services provided. $28,000 and $8,000, representing the fair value of the stock issued, has been included in selling, general and administrative expenses, and research and development expenses, respectively.
(b)
Transactions involving stock options
The Company has two incentive equity plans, under which a maximum of 10,000,000 options to purchase 10,000,000 common shares may be granted to officers, employees and consultants of the Company. The granting of options, and the terms associated with them, occurs at the discretion of the board of directors, who administers the plan. As of September 30, 2009, there were a total of 7,400,000 options granted under these plans, all with an exercise price of $0.04. 2,975,000 of the options expire on June 19, 2012; 4,425,000 expire on dates between May 12, 2013 and September 30, 2013. 7,025,000 of the options are fully vested; 375,000 vest on various dates between December 1, 2009 and December 1, 2010. 2,600,000 options remained available for grant under these plans as of September 30, 2009.
On August 17, 2009, the Company granted 300,000 options to a consultant in consideration for services rendered and to be rendered. 75,000 of these options vested immediately; the remaining 225,000 of these options vest on various dates between December 1, 2009 and December 1, 2010. The options have an exercise price of $0.04, and an expiry date of September 30, 2013, with provision for early expiration in the event the holder ceases to be engaged by the Company prior to the stated expiry date. $3,453, representing the fair value of options earned to September 30, 2009, has been included in expense. The fair value of options which vested at issuance was determined using the following weighted average assumptions: expected dividend yield 0%; risk-free interest rate of 2.0%; expected volatility of 194%; and an expected life of 4.1 years. The fair value of unvested options earned during the period was determined using the following weighted average assumptions: expected dividend yield 0%; risk-free interest rate of 1.9%; expected volatility of 195%; and an expected life of 4 years.
17
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
5. Stockholders’ deficiency (continued)
(b)
Transactions involving stock options (continued)
$2,822, representing the fair value of 300,000 options issued during 2008, and earned by non-employees during the current period, has been included in expense during the nine months ended September 30, 2009. The fair value of 150,000 of these options was determined using the following weighted average assumptions: expected dividend yield 0%; risk-free interest rate of 2.0%; expected volatility of 195%; and an expected life of 4 years. The fair value of a further 150,000 of these options was determined using the following weighted average assumptions: expected dividend yield 0%; risk-free interest rate of 1.9%; expected volatility of 180%; and an expected life of 3.7 years.
The fair value of unvested options held by non-employees will be determined periodically and included in expense over the vesting period.
In accordance with the terms of a stock option agreement, 900,000 options expired during the nine months ended September 30, 2009, upon the termination of the related employment agreement.
(c)
Transactions involving stock purchase warrants
On March 8, 2009, the 3,513,333 Series I warrants expired.
(d)
Stock-based compensation
The following table presents the total of stock-based compensation included in the expenses of the Company for the three and nine months ended September 30, 2009 and 2008:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||
| 2009 | 2008 | 2009 | 2008 |
|
|
|
|
|
Selling, general and administrative | $ 49,201 | $ 4,546 | $ 61,153 | $ 370,373 |
Research and development | 11,465 | 18,107 | 12,269 | 21,150 |
Total stock-based compensation included in expenses | $ 60,666 | $ 22,653 | $ 73,422 | $ 391,523 |
18
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
6. Interest and financing costs
Interest and financing costs include accrued interest, accretion and amortization of deferred financing costs relating to the 10% senior convertible notes, promissory notes, and the interest portion of capital lease payments.
7. Gain (loss) on extinguishment of debt, accounts payable and accrued liabilities
| Three Months Ended September 30, | Nine Months Ended September 30, | ||
| 2009 | 2008 | 2009 | 2008 |
Gain (loss) on settlement of accrued interest on 10% senior |
|
|
|
|
convertible notes (note 3) | $ -- | $ 2,078 | $ 63,767 | $ (2,503) |
Gain on settlement of accounts payable |
| 161,194 | 6,000 | 161,194 |
Gain on settlement of $50,950 in accrued liabilities and $878 in |
|
|
|
|
accounts payable to a former director of the Company, pursuant |
|
|
|
|
to the settlement of a legal action brought by the former director |
|
|
|
|
against the Company | -- | -- | -- | 17,094 |
| $ -- | $ 163,272 | $ 69,767 | $ 175,785 |
8. Loss per share
For the purposes of the loss per share computation, the weighted average number of common shares outstanding has been used. Had the treasury stock method been applied to the unexercised stock options and warrants, the effect on the loss per share would be anti-dilutive.
The following securities could potentially dilute basic earnings per share in the future but have not been included in diluted earnings per share because their effect was anti-dilutive:
| September 30, 2009 |
Stock options | 7,400,000 |
Series K stock purchase warrants | 3,120,000 |
Shares issuable on conversion of 10% senior | |
convertible notes | 157,975,439 |
| 168,495,439 |
19
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
9. Related party transactions
Included in 10% senior convertible notes payable (note 3) is $513,484 (December 31, 2008 – $513,484) payable to a director and to a company controlled by a director, and $24,956 (December 31, 2008 – $24,956) payable to an individual related to a director and a company controlled by an individual related to a director.
Included in promissory notes payable (note 2) is $69,467 (December 31, 2008 - $17,797) payable to a company controlled by a director, and $10,132 (December 31, 2008 - $nil) payable to a Company owned by a company controlled by a relative of a director of the Company.
$68,150 (December 31, 2008 – $22,071) in accrued interest charges relating to the 10% senior convertible notes and promissory notes is included in accrued liabilities at September 30, 2009. $15,876 (2008 - $10,549) and $46,836 (2008 - $26,015) is included in interest and financing costs for the three and six months ended September 30, 2009 and 2008, respectively.
10. Commitment and contingent liability
(a) Commitment
The Company’s contract for leased premises was terminated effective September 8, 2009. All known obligations relating to the lease have been reflected in the Company’s records for the period ended September 30, 2009.
Rent expense incurred under the operating lease for the three and nine months ended September 30, 2009, was $36,132 (2008 - $24,323) and $77,679 (2008 - $72,394), respectively.
(b) Contingent liability
Effective May 1, 2009, the Company entered into a contract for consulting services, pursuant to which part of the remuneration is contingent upon the Company achieving certain funding goals, whereupon the contingent amount will become immediately due and payable. As of September 30, 2009, the accumulated contingent liability under this arrangement was $25,000.
20
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
11. Supplementary cash flow information
The Company paid no income taxes during the nine months ended September 30, 2009, nor during the nine months ended September 30, 2008. Interest paid in cash during the nine months ended September 30, 2009 and nine months ended September 30, 2008 was $9,497 and $3,103, respectively.
Non-cash financing activities are excluded from the consolidated statements of cash flows. The following is a summary of such activities for the nine months ended September 30, 2009 and 2008:
| 2009 | 2008 |
|
|
|
Debt issuance costs | $ 1,400 | $ 20,370 |
Issuance of the Company’s common stock in settlement of interest payable |
|
|
on the 10% senior convertible notes | 90,520 | 37,092 |
Issuance of the Company’s common stock on conversion of the 10% senior |
|
|
convertible notes and accrued interest thereon | 108,100 | 202,901 |
Issuance of the Company’s 10% senior convertible notes in settlement of |
|
|
accounts payable and accrued liabilities | 23,280 | 169,532 |
Issuance of the Company’s 10% senior convertible notes in settlement of |
|
|
promissory notes and accrued interest thereon | -- | 456,758 |
Issuance of the Company’s 10% senior convertible notes in settlement of |
|
|
previously issued 10% senior convertible which matured during the period, |
|
|
plus accrued interest thereon | 1,146,571 | 1,510,425 |
Issuance of the Company’s common stock as incentive for entering into |
|
|
consulting services agreements | 29,600 | 240,000 |
Issuance of the Company’s common stock in settlement of accounts payable |
|
|
and accrued liabilities | 4,000 | 261,955 |
Issuance of the Company’s common stock in respect of consulting services |
|
|
rendered and to be rendered | -- | 43,200 |
Acquisition of office equipment through a capital lease arrangement | -- | 15,723 |
| $ 1,403,471 | $ 2,957,956 |
12. Fair value measurements
The carrying value of cash and cash equivalents, amounts receivable, accounts payable and accrued liabilities approximates fair value due to the short term to maturity of these instruments. The carrying value of the promissory notes and the 10% senior convertible notes approximates fair value, due to the issuance of new debt instruments having similar terms and conditions subsequent to September 30, 2009. The fair value of the obligation under capital lease at September 30, 2009 was approximately $10,428, based on the present value of future cash flows as of the balance sheet date, discounted at market rates.
21
VALIDIAN CORPORATION AND SUBSIDIARIES
A DEVELOPMENT STAGE ENTERPRISE
Notes to Consolidated Financial Statements
September 30, 2009
(In United States dollars)
(Unaudited)
13. Subsequent events
On October 5, 2009, the Company issued $75,000 of its 10% senior convertible notes for cash. The notes permit the holders, at any time, to convert all or a portion of the outstanding principal plus accrued interest into common stock of the Company at a ratio of one common share for each $0.03 of debt converted; the Company may pre-pay all or any portion of the balance outstanding on the note at any time without penalty or bonus, with permission from the holder; interest is accrued until the notes are either repaid by the Company or converted by the holder, or until paid at such time as the holder requests payment in writing. At the Company’s option, interest may be paid either in cash or in common shares of the Company. If interest is paid in common shares, the number of shares required for settlement will be calculated at the rate of conversion in effect for the note principal. The notes are payable on demand. The Company issued 375,000 shares of its common stock to the holders pursuant to the terms of the notes.
On October 12, 2009, the Company repaid $3,840 of its promissory notes, plus $52 in accrued interest thereon.
On October 27, 2009, the Company issued $55,000 of its 12% senior convertible notes for cash proceeds of $50,000, net of discount of $5,000. The notes permit the holders, at any time, to convert all or a portion of the outstanding principal plus accrued interest into common stock of the Company at a ratio of one common share for each $0.03 of debt converted; the Company may pre-pay all or any portion of the balance outstanding on the note at any time without penalty or bonus, with permission from the holder. The notes mature on December 8, 2009; in the event the note is not repaid at maturity, interest will accrue at the rate of 12% until the notes are either repaid by the Company or converted by the holder. At the Holder’s option, interest may be paid either in cash or in common shares of the Company. If interest is paid in common shares, the number of shares required for settlement will be calculated at the rate of conversion in effect for th e note principal. The Company issued 200,000 shares of its common stock to the holders pursuant to the terms of the notes.
On November 6, 2009, the Company issued $10,000 of its 10% senior convertible notes for cash. The notes permit the holder, at any time, to convert all or a portion of the outstanding principal plus accrued interest into common stock of the Company at a ratio of one common share for each $0.03 of debt converted; the Company may pre-pay all or any portion of the balance outstanding on the note at any time without penalty or bonus, with permission from the holder; interest is accrued until the notes are either repaid by the Company or converted by the holder, or until paid at such time as the holder requests payment in writing. At the Company’s option, interest may be paid either in cash or in common shares of the Company. If interest is paid in common shares, the number of shares required for settlement will be calculated at the rate of conversion in effect for the note principal. The notes are payable on demand. The Company issued 400,000 shares of its common stock to the holder pursuant to the terms of the notes.
The Company has evaluated subsequent events to November 13, 2009 in accordance with FASB 165 “Subsequent Events” and such events are disclosed herein.
22
Item 2. Management’s Discussion and Analysis or Plan of Operations
FORWARD-LOOKING INFORMATION
We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements that we make in this report. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements. This report contains statements that constitute “forward-looking statements.” These forward-looking statements can be identified by the use of predictive, future-tense or forward-looking terminology, such as “believes,” “anticipates,” “expects,” “estimates,” “plans,” “may,” or similar terms. These statements appear in a number of places in this report and include statements regarding our intent, belief or current expectations with respect to many things, some of which are:
·
trends affecting our financial condition or results of operations for our limited history;
·
our business and growth strategies;
·
our technology;
·
the internet; and
·
our financing plans.
We caution readers that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties. In fact, actual results most likely will differ materially from those projected in the forward-looking statements as a result of various factors. Some factors that could adversely affect actual results and performance include:
·
our limited operating history;
·
our lack of sales to date;
·
our requirements for additional capital and operational funding;
·
the failure of our technology and products to perform as specified;
·
the discontinuance of growth in the use of the Internet;
·
the enactment of new adverse government regulations; and
·
the development of better technology and products by others.
You should carefully consider and evaluate all of these factors. In addition, we do not undertake to update forward-looking statements after we file this report with the SEC, even if new information, future events or other circumstances have made them incorrect or misleading.
CRITICAL ACCOUNTING POLICIES
We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant accounting policies and methods used in preparation of the financial statements are described in note 2 to our 2008 Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2008. We evaluate our estimates and assumptions on a regular basis, based on historical experience and other relevant factors. Actual results could differ materially from these estimates and assumptions. The following critical accounting policies are impacted by judgments, assumptions and estimates used in preparation of our September 30, 2009 Interim Consolidated Financial Statements.
Research and development expenses:
We expense all of our research and development expenses in the period in which they are incurred. At such time as our product is determined to be commercially available, we will capitalize those development expenditures that are related to the maintenance of the commercial products, and amortize these capitalized expenditures over the estimated life of the commercial product. The estimated life of the commercial product will be based on management’s estimates, including estimates of current and future industry conditions. A significant change to these assumptions could impact the estimated useful life of our commercial product resulting in a change to amortization expense and impairment charges.
23
Stock based compensation:
The Company accounts for its stock-based payments in accordance with FASB Accounting Standards Codification Topic 718 “Compensation – Stock Compensation”, which requires all share-based payments, including stock options granted by the Company to its employees, to be recognized as expenses, based on the fair value of the share-based payments at the date of grant. For purposes of estimating the grant date fair value of stock-based compensation, the Company uses the Black Scholes option-pricing model, and has elected to treat awards with graded vesting as a single award. The fair value of awards granted is recognized as compensation expense on a straight-line basis over the requisite service period, which in the Company’s circumstances is the stated vesting period of the award.
RESULTS OF OPERATIONS
The Three Months Ended September 30, 2009 compared to the Three Months Ended September 30, 2008
Revenue: We had no revenue during the three months ended September, 2009, nor during the three months ended September 30, 2008. Since August 1999 we have directed all of our attention towards the completion, and sales and marketing of our software applications. We believe that if we are successful in our development and sales and marketing efforts, we will generate a source of revenue in the future from sales and/or licensing of our software applications.
Selling, general and administrative expenses: Selling, general and administrative expenses consist primarily of personnel costs, professional fees, communication expenses, occupancy costs and other miscellaneous costs associated with supporting our research and development, sales and marketing and investor relations activities. During the three months ended September 30, 2009, we incurred a total of $206,032, including $156,831 in cash-based expenses and $49,201 in stock-based expenses, as compared to $256,750, of which $252,204 was cash-based and $4,546 was stock-based expense, during the three months ended September 30, 2008. There was an overall decrease in selling, general and administrative expenses of $50,718 (20%), comprised of a $95,373 (38%) decrease in the cash-based component of this expense, which was partially offset by a $44,655 (982%) increase in the stock-based component.
The decrease in the cash-based component of this expense is due primarily to the departure of three full-time employees in our sales and administrative departments, who were not replaced.
The stock-based component of selling, general and administrative expense for the three months ended September 30, 2009 consisted of the fair value of options earned during the period, the fair value of stock issued to consultants in consideration of performance bonuses, and the fair value of stock issued as incentives relating to a consulting services agreement entered into during the period. The stock-based component of this expense for the three-month period ended September 30, 2008 consisted of the amortization of prepaid consulting fees recorded during the first and third quarters of 2008 on the issuance of common stock as partial consideration for consulting services rendered and to be rendered, and the fair value of options earned during the period. The issuance of common stock in consideration of bonuses during the three months ended September 30, 2009 had no comparable transaction during the three months ended September 30, 2008; this is the primary rea son for the reduction in stock-based remuneration.
We have made efforts to minimize selling, general and administrative expenses wherever possible, through measures such as reducing the number of personnel, postponing our Annual General Meeting, reducing the number of trade shows in which we participate, reducing travel costs, and delaying production of new promotional material. We will continue to carefully monitor our selling, general and administrative expenses as we work within current budgetary limits leading up to the full commercial release of our products.
Research and development expenses:Research and development expenses consist primarily of personnel costs directly associated with the development of our software applications. During the three months ended September 30, 2009, we incurred a total of $60,304, including $48,839 in cash-based expenses and $11,465 in stock-based expenses, as compared to $428,180, of which $410,073 was cash-based and $18,107 was stock-based expense, during the three months ended September 30, 2008. There was an overall decrease in research and development expenses of $367,876 (86%), comprised of a $361,234 (88%) decrease in the cash-based component of this expense, and a $6,642 (37%) decrease in the stock-based component.
Until January 2009, the majority of the development work was being performed by a Europe-based consulting group, for a fixed fee for deliverables which were set and reviewed monthly. Effective January 2009, this development work has been performed by several consultants working in Ottawa, Canada, who are engaged under variable-fee contracts. This change was implemented in order to provide greater control over the development being undertaken, while allowing flexibility in scaling the degree of work to our available funding and periodic development goals. During the three months ended September 30, 2008, the Europe-based consulting group increased their normal level of activity, as they undertook to meet target delivery dates for product upgrades, including those made in response to comments received from beta trial users
24
during the previous quarter, which were critical to our moving forward with our operational plans. As a result, we incurred unusually high fees for development work during that period, in addition to $125,000 for a software build system and delivery bonus. This anomaly in research and development activity during the three months ended September 30, 2008 resulted in a large decrease in the cash-based component of this expense for the three months ended September 30, 2009 as compared with the three months ended September 30, 2008.
The stock-based component of research and development expense for the three months ended September 30, 2009 and during the three months ended September 30, 2008 consisted of the fair value of options earned during the period, and the fair value of common stock granted to consultants in consideration of performance bonuses.
Interest and financing costs: Interest and financing costs during the three months ended September 30, 2009 and during the three months ended September 30, 2008 consisted of costs associated with our 10% senior convertible notes, our promissory notes and interest on the capital lease. During the three months ended September 30, 2009, we incurred $177,106 in interest and financing costs, a decrease of $319,258 (64%) from the $496,364 in interest and financing costs incurred during the three months ended September 30, 2008.
The $177,106 in interest and financing costs we incurred during the three months ended September 30, 2009 is comprised of $138,600 of interest payable to the holders of our debt; $38,319 of accretion of our 10% senior convertible notes and our promissory notes; and $187 in interest on the capital lease. The $496,364 in interest and financing costs we incurred during the three months ended September 30, 2008 is comprised of $107,036 of interest paid and payable to the holders of our debt; $366,008 of accretion of our 10% senior convertible notes and our promissory notes; and $23,320 of amortization of deferred financing costs.
Several factors contributed to the decrease in interest and financing costs. There was an increase of $892,872 in the principal balance of our 10% senior convertible notes during the period from September 30, 2008 to September 30, 2009, which was partially offset by a decrease of $267,862 in the principal outstanding on our promissory notes during the same period. This net increase of $625,010 in principal outstanding on our debt instruments resulted in a higher balance on which coupon based interest was charged, which resulted in an increase of $31,564 (29%) in interest paid and payable to the holders of our debt.
We failed to settle certain of our promissory notes and 10% senior convertible notes, and accrued interest thereon, when they became due in 2008 and 2009, and a significant portion of these notes remain in default as at September 30, 2009. In accordance with the default provision of the 10% senior convertible notes, and certain of the promissory notes, this has resulted in all of these notes becoming due and payable on demand as of the date of the default, or in the case of notes issued subsequent to the default, on the date of issuance, not withstanding any differing stated maturity date. Consequently, the accretion relating to the equity components of debt issued since the initial event of default, and the amortization of any finance charges incurred thereon, has occurred in the period of issuance.
As a result of the above, the accretion and finance charge components of interest and financing costs for the three months ended September 30, 2009, and for the three months ended September 30, 2008 relate only to those notes issued during these periods. The fair value of the equity components relating to notes issued during the three months ended September 30, 2008 was greater than the fair value of equity components relating to notes issued during the three months ended September 30, 2009, which resulted in a decrease of $327,689 (90%) in accretion; there were no finance costs incurred during the three months ended September 30, 2009.
Gain on extinguishment of debt and accrued liabilities: During the three months ended September 30, 2008 we realized a net gain of $163,272 on the settlement of accounts payable and accrued liabilities. There were no similar transactions during the three months ended September 30, 2009.
Foreign exchange gain (loss): Foreign exchange gain (loss) is comprised of realized and unrealized gains and losses on foreign currency translations, the majority of which relate to accounts payable and accrued liabilities, and obligations under our promissory notes, denominated in Canadian dollars. During the three months ended September 30, 2009 the Canadian dollar gained strength in relation to the United States dollar, resulting in overall losses on foreign currency translations of $52,146. During the three months ended September 30, 2008, the United States dollar gained strength in relation to the Canadian dollar, resulting in overall gains on foreign currency translations of $48,959.
25
Net loss: We incurred a loss of $498,158 ($0.01 per share) for the three months ended September 30, 2009, compared to a loss of $970,052 ($0.02 per share) for the three months ended September 30, 2008. Our revenues and future profitability are substantially dependent on our ability to:
·
raise additional capital to fund operations;
·
license software applications to a sufficient number of clients;
·
be cash-flow positive on an ongoing basis;
·
modify the successful software applications, over time, to provide enhanced benefits to then-existing users; and
·
successfully develop related software applications.
The Nine Months Ended September 30, 2009 compared to the Nine Months Ended September 30, 2008
Revenue: We had no revenue during the nine months ended September 30, 2009, nor during the nine months ended September 30, 2008. Since August 1999 we have directed all of our attention towards the completion, and sales and marketing of our software applications. We believe that if we are successful in our development and sales and marketing efforts, we will generate a source of revenue in the future from sales and/or licensing of our software applications.
Selling, general and administrative expenses: Selling, general and administrative expenses consist primarily of personnel costs, professional fees, communication expenses, occupancy costs and other miscellaneous costs associated with supporting our research and development, sales and marketing and investor relations activities. During the nine months ended September 30, 2009, we incurred a total of $423,137, including $361,984 in cash-based expenses and $61,153 in stock-based expenses, as compared to $1,122,646, of which $752,273 was cash-based and $370,373 was stock-based expense, during the nine months ended September 30, 2008. There was an overall decrease in selling, general and administrative expenses of $699,509 (62%), comprised of a $390,289 (52%) decrease in the cash-based component of this expense and a $309,220 (83%) decrease in the stock-based component.
The decrease in the cash-based component of this expense is due primarily to the departure of three full-time employees in our sales and administrative departments, and a reduction in the number of consultants engaged during the nine months ended September 30, 2009, as compared with the nine months ended September 30, 2008.
The stock-based component of selling, general and administrative expense for the nine months ended September 30, 2009 consisted of the amortization of prepaid consulting fees recorded in prior periods on the issuance of options as partial consideration for consulting services rendered and to be rendered, the fair value of options earned during the period, the fair value of stock issued to consultants in consideration of performance bonuses during the period, and the fair value of stock issued as incentives relating to three consulting services agreements entered into during the period. The stock-based component of this expense for the nine-month period ended September 30, 2008 consisted of the amortization of prepaid consulting fees recorded during the period on the issuance of common stock as partial consideration for consulting services rendered and to be rendered, the fair value of options earned by employees and consultants during the period, and the fair value o f stock issued as an incentive payment relating to a consulting services agreement entered into during the period. There were fewer consultants and employees engaged during the nine months ended September 30, 2009 as compared to the nine months ending September 30, 2008, and fewer stock based payments, which resulted in a reduction in stock-based remuneration.
We have made efforts to minimize selling, general and administrative expenses wherever possible, through measures such as reducing the number of personnel, postponing our Annual General Meeting, reducing the number of trade shows in which we participate, reducing travel costs, and delaying production of new promotional material. We will continue to carefully monitor our selling, general and administrative expenses as we work within current budgetary limits leading up to the full commercial release of our products.
Research and development expenses:Research and development expenses consist primarily of personnel costs directly associated with the development of our software applications. During the nine months ended September 30, 2009, we incurred a total of $132,548, including $120,279 in cash-based expenses and $12,269 in stock-based expenses, as compared to $654,770, of which $633,620 was cash-based and $21,150 was stock-based expense, during the nine months ended September 30, 2008. There was an overall decrease in research and development expenses of $522,222 (80%), comprised of a $513,341 (81%) decrease in the cash-based component of this expense and a $8,881 (42%) decrease in the stock-based component.
Until January 2009, the majority of the development work was being performed by a Europe-based consulting group, for a fixed fee for deliverables which were set and reviewed monthly. Effective 2009, this development work has been
26
performed by several consultants working in Ottawa, Canada, who are engaged under variable-fee contracts. This change was implemented in order to provide greater control over the development being undertaken, while allowing flexibility in scaling the degree of work to our available funding and periodic development goals.
During the three months ended September 30, 2008, the Europe-based consulting group increased their normal level of activity, as they undertook to meet target delivery dates for product upgrades, including those made in response to comments received from beta trial users during the previous quarter, which were critical to our moving forward with our operational plans. As a result, we incurred unusually high fees for development work during that period, in addition to $125,000 for a software build system and delivery bonus. This anomaly in research and development activity during the three months ended September 30, 2008, together with the move to variable-fee consulting contracts as noted above, resulted in a large decrease in cash-based research and development costs for the nine months ended September 30, 2009 as compared with the nine months ended September 30, 2008.
The stock-based component of research and development expense for the nine months ended September 30, 2009 and during the nine months ended September 30, 2008 consisted of the fair value of options earned during the period, and the fair value of common stock granted to consultants in consideration of performance bonuses. There were fewer stock based awards granted during the nine months ended September 30, 2009 as compared with the nine months ended September 30, 2008, which resulted in a reduction in the stock based component of research and development expense.
Interest and financing costs: Interest and financing costs during the nine months ended September 30, 2009 and during the nine months ended September 30, 2008 consisted of costs associated with our 10% senior convertible notes, our promissory notes and interest on the capital lease. During the nine months ended September 30, 2009, we incurred $469,023 in interest and financing costs, a decrease of $1,765,689 (79%) over the $2,234,712 in interest and financing costs incurred during the nine months ended September 30, 2008.
The $469,023 in interest and financing costs we incurred during the nine months ended September 30, 2009 is comprised of $409,999 of interest paid and payable to the holders of our debt; $57,069 of accretion of our 10% senior convertible notes and our promissory notes; $1,400 of deferred financing costs; and $555 in interest on the capital lease. The $2,234,712 in interest and financing costs we incurred during the nine months ended September 30, 2008 is comprised of $286,799 of interest payable to the holders of our debt; $1,844,387 of accretion of our 10% senior convertible notes and our promissory notes; $103,423 of amortization of deferred financing costs; and $103 in interest on the capital lease.
Several factors contributed to the decrease in interest and financing costs. There was an increase of $892,872 in the principal balance of our 10% senior convertible notes during the period from September 30, 2008 to September 30, 2009, which was partially offset by a decrease of $267,862 in the principal outstanding on our promissory notes during the same period. This net increase of $625,010 in principal outstanding on our debt instruments resulted in a higher balance on which coupon based interest was charged, resulting in an increase of $123,200 (43%) in interest paid and payable to the holders of our debt.
We failed to settle certain of our promissory notes and 10% senior convertible notes, and accrued interest thereon, when they became due in 2008 and 2009. As a result of the first of these instances on June 1, 2008, all of the 10% senior convertible notes and $100,000 of the promissory notes outstanding at that date became due and payable on demand, in accordance with the default provisions of the notes, as of the date of default. This resulted in the immediate accretion of all of these notes, and the full amortization of all deferred finance charges as of the date of the first event of default. Consequently, both the accretion and the finance charge components of interest and financing costs for the nine months ended September 30, 2009 relate only to those notes issued during the period, whereas these components for the nine months ended September 30, 2008 include not only the charges relating to notes issued during the period, but also the balance of un amortized accretion and finance charges for all previously issued notes. These factors resulted in a decrease of $1,787,318 (97%) and $102,023 (99%) in accretion and finance costs, respectively.
Gain on extinguishment of debt and accrued liabilities: During the nine months ended September 30, 2009 we realized a gain of $63,767 on the issuance of common stock in settlement of accrued interest on our 10% senior convertible notes, and gain of $6,000 on the settlement of accounts payable. During the nine months ended September 30, 2008, we realized a gain of $178,288 on the settlement of accounts payable and accrued liabilities, including a gain of $17,074 on the settlement of a legal action brought against the Company by a former director of the Company, which was partially offset by a loss of $2,503 on the issuance of common stock in settlement of accrued interest on our 10% senior convertible notes. A gain or loss on settlement of accrued interest through the issuance of common stock occurs as a result of a difference between the quoted market price of our stock at the date of settlement multiplied by the number of shares issued, as compared to the amount of interest settled. During the nine months ended September 30, 2009, and during the nine months ended September 30, 2008, the aggregate quoted market value of our stock issued in settlement of accrued interest was less than the aggregate accrued interest settled, resulting in a net gain.
27
Foreign exchange gain (loss): Foreign exchange gain (loss) is comprised of realized and unrealized gains and losses on foreign currency translations, the majority of which relate to accounts payable and accrued liabilities, and obligations under our promissory notes, denominated in Canadian dollars. During the nine months ended September 30, 2009 the Canadian dollar gained strength in relation to the United States dollar, resulting in overall losses on foreign currency translations of $95,726. During the nine months ended September 30, 2008, the United States dollar gained strength in relation to the Canadian dollar, resulting in overall gains on foreign currency translations of $69,832.
Net loss: We incurred a loss of $1,059,300 ($0.01 per share) for the nine months ended September 30, 2009, compared to a loss of $3,771,595 ($0.07 per share) for the nine months ended September 30, 2008. Our revenues and future profitability are substantially dependent on our ability to:
·
raise additional capital to fund operations;
·
license software applications to a sufficient number of clients;
·
be cash-flow positive on an ongoing basis;
·
modify the successful software applications, over time, to provide enhanced benefits to then-existing users; and
·
successfully develop related software applications.
LIQUIDITY AND CAPITAL RESOURCES
General: Since inception, we have funded our operations from private placements of debt and equity securities. In addition, until September 1999 we derived revenues from consulting contracts with affiliated parties, the proceeds of which were used to fund operations. Until such time as we are able to generate adequate revenues from the licensing of our software applications, we cannot assure that we will be successful in raising additional capital, or that cash from the issuance of debt securities, the exercise of existing warrants and options, and the placements of additional equity securities, if any, will be sufficient to fund our long-term research and development and selling, general and administrative expenses.
Our cash and cash equivalents decreased by $55,308 during the nine months ended September 30, 2009, from a balance of $59,418 at December 31, 2008, to $4,110 at September 30, 2009. Our net loss of $1,059,300 during the period, and resulting cash used in operations of $414,793, were partially offset by an increase in cash resulting from the issuance of $260,000 of 10% senior convertible notes, and $89,828, net of repayments, from the issuance of promissory notes. Our cash and cash equivalents increased by $3,219 during the nine months ended September 30, 2008. Our net loss of $3,771,595 during the period, and resulting cash used in operations of $815,534, were offset by an increase in cash resulting from the issuance of $385,000 of 10% senior convertible notes, and $462,892, net of repayments and issuance costs, from the issuance of promissory notes.
We added an explanatory paragraph to our interim consolidated financial statements for the nine months ended September 30, 2009. It states that our economic viability is dependent on our ability to finalize the development of our principal products, generate sales and finance operational expenses, and that these factors, together with our lack of revenues to date; our negative working capital; our loss for the year, as well as negative cash flow from operating activities in the same period; and our accumulated deficit, raise substantial doubt regarding our ability to continue as a going concern. At September 30, 2009, we had negative working capital of $7,365,214 and an accumulated deficit during the development stage of $33,393,838; for the nine months then ended we had a net loss of $1,059,300, and negative cash flow from operations of $414,793. Furthermore, the Company failed to settle $1,800,000 in 10% senior convertible notes plus accrued interest th ereon of $277,082 when they matured in 2008; $3,232,302 in 10% senior convertible notes plus accrued interest thereon of $347,404 when they matured in 2009; $100,000 in promissory notes when they matured in 2008; and $64,281 in promissory notes when they matured in May and June 2009. $2,655,070 of these notes, plus $358,883 in interest accrued thereon, were unpaid as of September 30, 2009. All of the 10% senior convertible notes, as well as $164,281 of the promissory notes were in default at September 30, 2009 in accordance with the default provisions of the respective notes, and as a result are due and payable on demand.
On January 1, 2006 we entered into an agreement with a Value Added Reseller (“VAR”), pursuant to which we granted the VAR a license to sell our software to the VAR’s customers for a period of three years. As a result of subsequent delays in completing certain of our software products to a market ready stage, we have agreed to extend the expiry of this agreement, with terms to be negotiated upon completion of our current development initiatives. Our fee for this license, excluding applicable sales taxes, was $155,000, of which $151,650 has been collected. We will recognize revenue in connection with this sale once all of the criteria required for us to do so as set out in our accounting policies, have been met. We did not make any sales during the nine months ended September 30, 2009.
28
We anticipate sales during the fourth quarter of 2009, however we cannot be assured that this will be the case. During the nine months ended September 30, 2009, one of our employees left the Company, our contract with a Europe-based development consultant was terminated, and we retained the services of three part-time consultants. During the next 6 months we expect to engage one officer and director; we do not expect to hire additional personnel unless we are successful in raising significant funds through the issuance of our debt or equity securities. We do not expect to make any material commitments for capital equipment expenditures during the next 12 months.
We have an immediate requirement for additional working capital in order to proceed with our business plan. We review our cash needs and sources on a month-to-month basis and we are currently pursuing appropriate opportunities to raise additional capital to fund operations. Additional sources of capital could involve issuing equity or debt securities. We have engaged consultants to provide advice to us with respect to the raising of capital. However, additional funding may not be available to us on reasonable terms, if at all. The perceived risk associated with the possible sale of a large number of shares of our common stock could cause some of our stockholders to sell their stock, thus causing the price of our stock to decline. In addition, actual or anticipated downward pressure on our stock price due to actual or anticipated issuance of stock could cause some institutions or individuals to engage in short sales of our common st ock, which may itself cause the price of our stock to decline. We may be unable to raise additional capital if our stock price is too low. A sustained inability to raise capital could force us to limit or curtail our operations.
We expect the level of our future operating expenses to be driven by the needs of our research and development and marketing programs, offset by the availability of funds. In addition, we have since inception taken steps to keep our expenses relatively low and conserve available cash until we begin generating sufficient operating cash flow.
Sources of Capital: Our principal sources of capital for funding our business activities have been the private placements of debt and equity securities. During the nine months ended September 30, 2009, we issued $81,103, net of repayments and discounts, of promissory notes and $260,000 of 10% senior convertible notes, which generated cash to fund operations. During this period, we issued a further $1,146,571 of our 10% senior convertible notes in settlement of previously issued 10% senior convertible notes which matured during 2008 and 2009, plus accrued interest thereon; $20,000 of our 10% senior convertible notes in settlement of accounts payable; and $3,280 in promissory notes as consideration for the partial settlement of accrued liabilities, all of which reduced the amount of cash required to settle these obligations. During this period we also issued 7,261,508 common shares in settlement of accrued interest on our 10% senior convertibl e notes; 3,603,333 common shares on the conversion of $108,100 in principal of our 10% senior convertible notes; 333,000 common shares in settlement of accounts payable; and 100,000 common shares as consideration for finance fees relating to the issuance of promissory notes, all of which reduced the amount of cash which would otherwise have been required to settle these obligations. Also during the nine months ended September 30, 2009, we issued 1,800,000 common shares as incentives for entering into consulting agreements, and a further 1,800,000 common shares as consideration for bonuses to consultants, which reduced the cash remuneration which would otherwise have been required to obtain the services of the consultants.
During the period from October 1, 2009 to November 13, 2009, we issued $135,000 in senior convertible notes, net of discounts, the cash proceeds of which were used to fund operations.
The Company has not entered into any off-balance sheet arrangements which would have provided the Company with a source of capital.
Uses of Capital: Over the past several years, we have scaled our development activities to the level of available cash resources. Cash-based research and development expenses for the nine months ended September 30, 2009 decreased by approximately 81% as compared to the nine months ended September 30, 2008, as a result of our efforts to conduct our research and development activities within the constraints of our available cash. Cash-based selling, general and administrative expenses for the nine months ended September 30, 2009 decreased by approximately 52% as compared to the nine months ended September 30, 2008, also as a result of cash conservation efforts.
Our plans with respect to future staffing will be dependant upon our ability to raise additional capital. We have not entered into any off-balance sheet arrangements which would have resulted in our use of capital.
ITEM 3. QUANTITATIVE AND QUALITIVE DISCLOSURES ABOUT MARKET RISK
N/A
29
ITEMS 4 AND 4T. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The term “disclosure controls and procedures” is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, or the Exchange Act. This term refers to the controls and procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission.
It is management’s responsibility to establish and maintain adequate internal control over all financial reporting pursuant to these rules. Our management, including our principal executive officer and principal financial officer, have reviewed and evaluated the effectiveness of our disclosure controls and procedures as of a date within ninety (90) days of the filing date of this report. Based on that evaluation, our President, Chief Executive Officer and Chief Financial Officer has concluded that our controls and procedures were not effective as of the end of the period covered by this Report to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate to allow tim ely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
No change in our internal control over financial reporting occurred during the nine months ended September 30, 2009 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Management’s Report on Internal Controls over Financial Reporting
Management of Validian Corporation (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers and effected by the Company’s Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements in accordance with U.S. generally accepted accounting principles.
The Company’s internal control over financial reporting is not supported by written policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the Company’s transactions and dispositions of the Company’s assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of the Company’s management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
Because of its inherent limitation, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate. In connection with the preparation of the Company’s unaudited interim consolidated condensed financial statements, management undertook an assessment of the effectiveness of the Company’s internal control over financial reporting as of September 30, 2009. Management’s assessment, based on criteria established in our internal control procedures policies, included an evaluation of the design of the Company’s internal control over financial reporting but did not include testing of the operational effectiveness of those controls because our evaluation concluded that our system of internal controls was not effective in preventing or detecting misstatements.
Based on this assessment, management has concluded that as of September 30, 2009, the Company’s internal control over financial reporting was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.
In connection with the audit of our consolidated financial statements for the year ended December 31, 2008, our independent registered public accounting firm advised the Board of Directors and management of certain significant internal control deficiencies that they considered to be, in the aggregate, a material weakness. In particular, our independent registered public accounting firm identified the following weaknesses in our internal control system at
30
December 31, 2008: (1) a lack of segregation of duties; (2) the lack of timely preparation of certain back up schedules; (3) finance staff’s lack of sufficient technical accounting knowledge; (4) a lack of independent Board oversight; and (5) signing authority with respect to corporate bank accounts. The independent registered public accounting firm indicated that they considered these deficiencies to be reportable conditions as that term is defined under standards established by the Public Company Accounting Oversight Board. A material weakness is a significant deficiency in one or more of the internal control components that alone or in the aggregate precludes our internal controls from reducing to an appropriately low level of risk that material misstatements in our financial statements will not be prevented or detected on a timely basis. We considered these matters in connection with the period-end closing of accou nts and preparation of the related consolidated financial statements and determined that no prior period financial statements were materially affected by such matters. Notwithstanding the material weakness identified by our independent registered public accountants, we believe that the financial statements, and other financial information included in this report, fairly present in all material respects, the financial condition, results of operation and cash flows of the Company as of, and for, the periods represented in this report.
Our size has prevented us from being able to employ sufficient resources at this time to enable us to have an adequate level of supervision and segregation of duties within our internal control system. We will continue to monitor and assess the costs and benefits of additional staffing within the Company.
We were unable to eliminate the identified weaknesses with respect to the period covered by this report. Set forth below is a discussion of the significant internal control deficiencies which have not been remediated.
Lack of segregation of duties. Since commencing the development phase of our operations in August 1999, our size has prevented us from being able to employ sufficient resources to enable us to have an adequate level of supervision and segregation of duties within our internal control system. During the period from January 2007 to February 2008, we had only three people involved with the processing of accounting entries: the Office Administrator, the Controller and the Chief Financial Officer. It was therefore difficult to effectively segregate accounting duties. During this period, we made attempts to segregate duties as much as practicable, however there was insufficient volume of transactions to justify additional full time staff. The office administrator and the Chief Financial Officer resigned, effective February 15, 2008 and July 10, 2008, respectively. While our Chief Executive Officer has assumed the roll of the Chief Finan cial Officer on an interim basis, we nonetheless are inadequately staffed at this time to ensure a sufficient level of segregation of duties. As a result, this significant internal control deficiency had not been remediated as of the end of the period covered by this report, nor do we know if we will be able to remediate this weakness in the foreseeable future. However, we will continue to monitor and assess the costs and benefits of additional staffing.
Lack of timely preparation of back up schedules. Throughout 2008 and 2009, we were able to complete most of our back up schedules prior to the arrival of our independent registered public accountants’ audit staff, however, during this time we consistently experienced a lack of complete preparedness. As such, we believe that this material weakness had not been remediated as of the end of the period covered by this report. Inasmuch as this deficiency is related to our lack of adequate staffing, which is a condition which our size prohibits us from remediating, we do not know if we will be able to remediate this weakness in the foreseeable future. We will continue to review our interim procedures, and to make changes wherever practicable to assist in remediating this deficiency.
Finance staff’s lack of sufficient technical accounting knowledge. Due to the limited number of personnel, our finance staff does not have sufficient technical accounting knowledge to address all complex and non-routine accounting transactions that may arise. These transactions are sometimes extremely technical in nature and require an in-depth understanding of generally accepted accounting principles. As a result of this pervasive deficiency, these types of transactions may not be recorded correctly, potentially resulting in material misstatements of the financial statements of the Company. To address this risk, the Company has a control whereby it consults with its auditors and advisors, as needed, in conjunction with the recording and reporting of complex and non-routine accounting transactions. Management has concluded that this control was not operating effectively during the year, as the Company did not consult with external advisors on certain complex and non-routine transactions and on certain of these transactions, errors were identified by our auditors. All material misstatements detected by the audit have been corrected by the Company. Any changes in the staff complement will be dependant upon the growth of our operations and the number of our staff to allow further technical accounting knowledge to address all complex and non-routine accounting transactions. Management will continue to review existing consultation controls and, if appropriate, implement changes to its current internal control processes whereby more effective consultation will be performed.
Lack of independent Board oversight. Our Board of Directors consists of only one individual who is also the Company’s sole signing officer. We have experienced difficulties in identifying suitable candidates to serve as independent Board members because of our size, the perceived additional liability to the public by prospective candidates and the excessive additional costs associated with the selection of a candidate including director fees and director liability insurance. As such, our Board lacks the controls, depth of knowledge and perspective that such independence would provide.
31
Signing authority with respect to corporate bank accounts. Since the departure of our Chief Financial Officer and Treasurer in July 2008, the positions of Director, President, Chief Executive Officer, Chief Financial Officer, Executive Vice President, Secretary and Treasurer have been held by one person. This individual has sole signing authority for the Company’s bank accounts. Our Controller monitors our bank accounts on a regular basis, however there can be no assurance that unauthorized or unsupported transactions will not occur.
If we are unable to remediate the identified material weakness, there is a more than remote likelihood that a material misstatement to our SEC reports will not be prevented or detected, in which case investors could lose confidence in the accuracy and completeness of our financial reports, which could have an adverse effect on our ability to raise additional capital and could also have an adverse effect on our stock price.
As required by the SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Report. This evaluation was performed under the supervision and with the participation of our President and Chief Executive Officer, who is also the Chief Financial Officer and Treasurer. Based upon that evaluation, our President and Chief Executive Officer has concluded that our controls and procedures were not effective as of the end of the period covered by this Report due to existence of the significant internal control deficiencies described above.
32
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1a. Risk Factors
In addition to other information set forth in this Report, you should carefully consider the risk factors previously disclosed in “Item 1A. to Part 1” of our Annual Report on Form 10-K for the year ended December 31, 2008. There were no material changes to these risk factors during the nine months ended September 30, 2009.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On October 5, 2009, the Company issued 375,000 shares of its common stock to an accredited investor pursuant to the terms of $75,000 in principal amount of its 10% senior convertible notes, which were issued to the investor on the same date.
On October 27, 2009, the Company issued 200,000 shares of its common stock to an accredited investor pursuant to the terms of $55,000 in principal amount of its 12% senior convertible notes notes, which were issued to the investor on the same date.
On November 6, 2009, the Company issued 400,000 shares of its common stock to an accredited investor pursuant to the terms of $10,000 in principal amount of its 10% senior convertible notes, which were issued to the investor on the same date.
The foregoing securities were issued in reliance on the exemption provided by Section 4(2) of the Securities Act of 1933, as amended, and the rules promulgated thereunder.
Item 3. Defaults upon Senior Securities
We failed to settle $1,800,000 in 10% senior convertible notes plus accrued interest thereon of $277,082 when they matured in 2008; $3,232,302 in 10% senior convertible notes plus accrued interest thereon of $347,404 when they matured in 2009; $100,000 in promissory notes when they matured in 2008; and $64,281 in promissory notes when they matured in May and June 2009. $2,655,070 of these notes, plus $358,883 in interest accrued thereon, were unpaid as of September 30, 2009, and were therefore in default and due and payable on demand. Additionally, in accordance with the default provisions of the notes, this failure to settle the matured notes resulted in the remaining 10% senior convertible notes and accrued interest thereon becoming also due and payable on demand. Notwithstanding our obligation to repay these amounts immediately, the note holders have verbally communicated to management their willingness to continue holding the notes until new terms are negot iated. We will accrue interest on these unpaid balances at the coupon rate until a settlement is reached.
Until such time as the matured notes plus accrued interest thereon are settled, all of the 10% senior convertible notes, and $164,281 of the promissory notes will remain in default.
Item 4. Submission of Matters to a Vote of Security Holders
None
Item 5. Other Information
None
Item 6. Exhibits
(a) Exhibits.
31.1 |
| Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2 |
| Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1 |
| Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2 |
| Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
33
SIGNATURES
In accordance with requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
VALIDIAN CORPORATION
By: /s/ Bruce Benn
Bruce Benn
President, Chief Executive Officer
and Chief Financial officer
(principal executive officer)
(principal financial and accounting officer)
Dated: November 19, 2009
In accordance with the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: /s/ Bruce Benn
Bruce Benn
President, Chief Executive Officer
and Chief Financial officer
(principal executive officer)
(principal financial and accounting officer)
Dated: November 19, 2009
34
